For Patients: News

Wednesday ~ February 13, 2008

Global Rise in Breast Cancer Due to Western Lifestyles

Global Rise in Breast Cancer Due to Western Lifestyles

Of all the exports from our modern world, breast cancer ranks as among the most dubious. Once thought to be a disease of the rich, it is now a global epidemic.

The rise of the cancer in Europe and America – cases have jumped 80 per cent in the UK since the 1970s – is being mirrored across the world. And scientists say increasing prosperity and the “Westernisation” of traditional lifestyles is to blame.

A richer diet, smaller families, delayed childbearing and reduced breast-feeding have driven the increase in the West, together with rising obesity and increased alcohol consumption, specialists say. Now these trends are being seen everywhere – with a growing burden of malignant disease in their wake.

An estimated 1.3 million new cases were diagnosed around the world last year. It is the commonest cancer in the UK and across Europe, even though it affects almost only one gender. In 2006, it outranked lung cancer, which affects both sexes, for the first time.

In Japan, Singapore and Korea – countries once renowned for their low rates – cases have doubled or tripled in the past 40 years.

In China, urban cancer registries have recorded 20 to 30 per cent increases in the past decade. India has seen similar rises and cases have doubled in parts of Africa. There are doubts, especially in Africa, about how far better recording has contributed to the apparent rise. But scientists agree that the disease is rampaging across the globe.

However, they disagree about the best way to curb it. Some claim the best hope lies in developing a preventive drug – a hormonal cocktail that would act like a vaccine and provide lifelong protection – and criticise the world’s failure to focus attention on it.

Others demand political action, raising public awareness and galvanising governments to provide screening and early treatment that gives women the best chance of surviving. A third school of thought emphasises the need for a public health strategy to highlight the risks of alcohol, obesity and lack of exercise.

Peggy Porter, of the Fred Hutchinson Research Centre in Seattle, Washington, writing in the current New England Journal of Medicine, says the world must wake up to the growing threat.

“As more countries modernise, more women will enter an increasingly sedentary workforce, delay childbearing, exert control over their reproductive lives, live longer and eat a more Westernised diet. Their breast cancer rates will no doubt increase. It is crucial that women’s awareness of their risk and their expectations of their government and the medical community regarding detection and treatment increase at a similar rate.”

Professor Porter said the biggest barrier to improved care for women was ignorance. “In a lot of countries, women are still afraid to know. When Betty Ford [wife of US President Gerald Ford] admitted she had breast cancer in 1974, it changed the world. Women who had seen it as a death sentence became willing to talk about it, pushed for more care and more research. Other countries need to follow that lead.”

Valerie Beral, head of the Cancer Research UK epidemiology unit at Oxford University, said that to blame Westernisation was to miss the central cause – changes in child-bearing.

“We don’t need to seek subtle explanations when we know the main one. China has gone from the six-child family to the one-child family in a couple of generations. Most women in the past had six or seven children – it was fairly standard across the world. Each child was breast fed for two to two-and-a-half years, which meant they stopped ovulating and didn’t conceive. The hormonal changes that occur around child-bearing and during breast-feeding are protective for life.”

We need to investigate the nature of this hormonal protection and synthesise it, she said. “If we could find out why child-bearing gives life-long protection against breast cancer we might develop a hormonal cocktail that could be given to women at age 18 for a year which would have the same effect. I am frustrated that this is not a research priority.”

Peter Boyle, head of the International Agency for Cancer Research in Lyon, which will publish global cancer rates next month, said alcohol was the most worrying driver for younger women. “The rise is a huge problem and one which is growing enormously quickly. There are places which 30 years ago had very low rates where it is growing very rapidly. In every region it is the commonest or second most common cancer.

“My concern is over the rise in drinking, especially among young women. For each single unit of alcohol per day, the risk rises by 7 per cent. It’s the ladettes who hit the bars on a Friday night that I worry about.”

Why Rates Have Risen

* The rising breast cancer rates around the world are linked to increased exposure to the female hormone oestrogen, because of changes in reproduction and diet.

* Improved nutrition means girls reach puberty earlier and women have the menopause later. A century ago, girls had their first periods at 16 and 17, but today it is morelikely to be 12 to 13.

* Each year that the menopause is delayed increases the risk of contracting breast cancer by 3 per cent.

* Increased numbers of women going out to work has led to later births, smaller families and fewer women breastfeeding. Each year that childbirth is postponed beyond the mid-20s increases the breast cancer risk by 3 per cent.

* The more children a woman has, the lower her risk of breast cancer so the trend towards smaller families has increased many women’s exposure.

* Breast cancer rates vary widely around the world. Japan has one fifth of the cases diagnosed in the US. However, Japanese women who move to the US rapidly acquire the same risk as American women.

* Breast cancer in the UK has risen by 84 per cent since the 1970s. In 2005, 38,212 women were diagnosed with the disease.

* Breast cancer is the commonest cancer in the UK even though it mostly affects one sex (there are a few hundred cases in men). Lung cancer, the next most common, which affects both sexes, was diagnosed in 30,997 men and women in 2005.

Source: The Independent (UK)

Pill Has Stopped 100,000 Deaths

Pill Has Stopped 100,000 Deaths

FACT: The pill was launched in the UK in 1961

At least 100,000 deaths from ovarian cancer have been prevented worldwide by the contraceptive pill over 50 years, research has concluded.

The Oxford University team said the pill’s rising popularity meant 30,000 new cases will soon be avoided each year, the Lancet reported.

The findings were based on analysis of 45 previous studies.

Calls for the pill to be available without prescription were strengthened by the study, the Lancet’s editor said.

=================================================

“We strongly endorse more widespread over-the-counter
access to a preventive agent that can not only prevent
cancers but also demonstrably save the lives of tens of
thousands of women.”

- Richard Horton
Editor, The Lancet

=================================================

The link between oral contraceptives and lower rates of ovarian cancer is long-established, but the study is one of the most detailed attempts to work out how effective it is across a woman’s lifetime.

Even though the dose of hormones in the 1960s and 1970s pill was roughly double the amount in today’s versions, this did not seem to make a difference to the level of protection offered, the researchers said.

And they said protection against cancer can continue decades after a woman has stopped taking the pill.

The relationship between the contraceptive pill and cancer is not all good news - there have been fears about short-term increases in the risk of breast and cervical cancer.

But researcher Sir Richard Peto said that young women did not have to worry about this risk.

“The eventual reduction in ovarian cancer is bigger than any increase in other types of cancer caused by the pill,” he said.

Dr Lesley Walker, of Cancer Research UK, said: “All women who have taken the pill or are currently taking it should be reassured by this study.”

Easy Access
She urged anyone with concerns about it to talk to their GP or family planning clinic.

Julie Bentley, from the FPA (formerly the Family Planning Association) said: “This is great news for women as it is further assurance that the contraceptive pill provides lasting protection against ovarian cancer.”

And Lancet editor Richard Horton said that the new evidence was a compelling reason to make it easier to obtain the pill.

“There are few drugs available that confer powerful and long-lasting protection against a highly lethal malignancy after such a short exposure.

“We strongly endorse more widespread over-the-counter access to a preventive agent that can not only prevent cancers but also demonstrably save the lives of tens of thousands of women.”

Currently, a woman who wants to take the pill needs a prescription from her GP to do so as it should not be given to women with a history of blood clots and heart and liver disease.

The Medicines and Healthcare Products Regulatory Agency has said there are no plans to make it available over the counter.

Source: BBC News

Connection Found Between Inactive Lifestyles and Accelerated Aging

Connection Found Between Inactive Lifestyles and Accelerated Aging

Those who are physically active in their leisure time seem to be younger than those with inactive lifestyles, from a biological perspective.

Generally, people who participate in regular exercise already have lower rates of cardiovascular disease, type 2 diabetes, cancer, high blood pressure, obesity, and osteoporosis. However, according to a report in the January 28 issue of Archives of Internal Medicine, one of the JAMA/Archives journals, there might be more to this than just avoiding these diseases. “A sedentary lifestyle increases the propensity to aging-related disease and premature death,” the authors write. “Inactivity may diminish life expectancy not only by predisposing to aging-related diseases but also because it may influence the aging process itself.”

A group of 2,401 white twins was studied by Lynn F. Cherkas, Ph.D., of King’s College London, and colleagues. The team administered questionnaires related to physical activity level, smoking habits, and social and economic factors. Notably, the participants also provided a blood sample, and DNA was extracted from the white blood cells (leukocytes.)

The leukocyte DNA samples were analyzed for the length of their repeating sequences at each end of the chromosomes. These sequences, called telomeres, may serve as a marker of biological age, as they progressively shorten over time.

As expected, telomere length decreased with age, contributing to an average loss of 21 nucleotides (the basic structural units of DNA) per year. Less physically active men and women displayed shorter leukocyte telomeres than those who were more active in their leisure time. Even after normalizing for various factors, this trend remained. “Such a relationship between leukocyte telomere length and physical activity level remained significant after adjustment for body mass index, smoking, socioeconomic status and physical activity at work,” observe the authors. “The mean difference in leukocyte telomere length between the most active [who performed an average of 199 minutes of physical activity per week] and least active [16 minutes of physical activity per week] subjects was 200 nucleotides, which means that the most active subjects had telomeres the same length as sedentary individuals up to 10 years younger, on average.” When pairs of twins with different levels of physical activities were subsequently analyzed, similar results were shown.

The authors suggest a few mechanisms by which more sedentary lifestyles might contribute to telomere degeneration. One could be damage to cells caused by exposure to oxygen, called oxidative stress. Increased inflammation in sedentary persons may also create this effect Additionally, telomere length has been linked to perceived stress levels. This psychological stress may be reduced by physical activity, thus lessening its severity on telomeres and the aging process.

The authors conclude, relating this to daily life. “The U.S. guidelines recommend that 30 minutes of moderate-intensity physical activity at least five days a week can have significant health benefits,” state the authors. “Our results underscore the vital importance of these guidelines. They show that adults who partake in regular physical activity are biologically younger than sedentary individuals. This conclusion provides a powerful message that could be used by clinicians to promote the potential anti-aging effect of regular exercise.”

This study was supported in part by a grant from the Welcome Trust, grants from the National Institutes of Health and a grant from The Healthcare Foundation of New Jersey. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

The Association Between Physical Activity in Leisure Time
and Leukocyte Telomere Length
Lynn F. Cherkas, PhD; Janice L. Hunkin, BSc; Bernet S. Kato, PhD; J. Brent Richards, MD; Jeffrey P. Gardner, PhD; Gabriela L. Surdulescu, MSc; Masayuki Kimura, MD, PhD; Xiaobin Lu, MD; Tim D. Spector, MD, FRCP; Abraham Aviv, MD
Arch Intern Med. 2008;168[2]:154-158
Click here for Abstract through the Archives of Internal Medicine

Source: Medical News Today

Facelifts Fuel Cosmetic Op Rise

Facelifts Fuel Cosmetic Op Rise

A record number of women having facelifts fuelled a 12% rise in cosmetic operations in Britain last year, figures show.

A total of 32,453 surgical procedures were carried out, compared with 28,921 in 2006, the British Association of Aesthetic Plastic Surgeons said.

Some 91% of patients were women, but “tummy tucks” and breast reductions on men also increased to record levels.

Association members reported a 37% rise in face or necklifts on women to 4,238.

=========================================

“It is crucial that people do their research
carefully when choosing a provider.”

- Douglas McGeorge
British Association of Aesthetic Plastic Surgeons

=========================================

The annual audit covers only members of the association, so the true number of procedures is likely to be higher.

The most popular operation for women remained breast enlargement surgery, with 6,847 cases.

This was followed by eyelid surgery (5,148 - up 13%), face or neck lifts, liposuction (3,990 - up 15%), and breast reduction (3,178).

The association says it is the rise of non-surgical versions, involving fillers and Botox, that is responsible for the increase in facelifts.

Rajiv Grover, the association’s secretary, said: “Ten years ago there may not have been much choice between a face cream and a facelift, but more recently non-surgical procedures have introduced a large number of patients to gradual facial rejuvenation.”

Liposuction
The most popular operation among men was rhinoplasty, or nose job, with more than 700 men taking this option, a rise of more than a third.

Liposuction was the next most popular, with 582 procedures (up 18%), then eyelid surgery, ear correction and neck or facelifts (230 - up 21%).

There were 224 breast reductions on men, up 27% on the 177 in 2006, and 10 times the 22 operations carried out in 2002.

The biggest rise was in “tummy tucks” as 98 men underwent the procedure, up from 61 in 2006 - a rise of 61%.

Douglas McGeorge, the association’s president, said that the continuing rise in operations reflected a “continued acceptance” of cosmetic surgery.

“Wide media coverage has helped to educate the public about the latest advances and choices available, but it is crucial that people do their research carefully when choosing a provider.”

Which? Concerns

An investigation by the consumer group Which? recently found cases in which would-be patients felt pressurised into going ahead with cosmetic procedures such as “non-surgical” facelifts, often after misleading marketing.

Campaigner Jenny Driscoll said: “Our investigations have revealed a relaxed attitude to non-surgical treatments such as Botox and it is worrying to find that it is being prescribed by doctors without them having seen or even spoken to the patient.

“The Health and Social Care Bill is currently going through Parliament and Which? will be calling for the government to make sure that regulation of this industry is more robust.”

Source: BBC News

Doctor D. Schwab Alphasomes™ RC Rejuvenate and Correct

Doctor D. Schwab Alphasomes™ RC Rejuvenate and Correct

Luxury Vegetable-Derived Cream Acts as Immediate BOTOX Alternative

(San Diego, CA) Doctor D. Schwab, a unique rejuvenating and stimulating anti-aging line for mature skin manufactured by San Diego based CA BOTANA, has introduced its most luxurious product, Alphasomes™ RC Rejuvenate and Correct to combat the signs of aging.

Alphasomes™ is the only product of its kind on the market today which contains a proprietary blend of vegetable ingredients and transformers which act as an alternative to Botox. The cream’s re-densifying action helps to fill wrinkles and smooth out expression lines. Additionally, Alphasomes™prevents the breakdown of the skin’s elastin, promotes collagen production, corrects loss of skin tone and firmness, and prevents dehydration and the development of new wrinkles and crow’s feet.

One of Alphasomes™ most unique ingredients is Euk-134, which is a powerful antioxidant with anti-inflammatory properties that mimics the activity of natural skin enzymes to protect skin tissue against free radicals and the damaging effects of the sun.

Alphasomes™ produces a result of plumper, younger looking skin without invasive medical treatments. Wrinkles melt away within minutes of application eliciting supple, vibrant and healthy skin.

Alphasomes™ is sold at upscale spas and physicians’ offices across the country and carries a price of $500 per luxury-boxed Doctor D. Schwab jar.

About CA BOTANA International, Inc.
CA BOTANA is a leading manufacturer of personal care products with worldwide distribution. With over 40 years of in-house research, CA BOTANA has studied the effects of sea extracts, plants, herbs and vitamins and has integrated it with the latest skin care technology to satisfy today’s consumers.

CA BOTANA’s natural skin care products were developed by drawing information from Ayurvedic Medicine, Chinese, ancient Egyptian and American Indian herbology and aromatherapy along with the expertise of skilled herbalists and physiotherapists. CA BOTANA is among the first in the personal care product industry to incorporate this knowledge about natural therapies into their products.

CA Botana
www.doctorschwabca.com

Shedding Some Light on the Recent BOTOX® Deaths

Shedding Some Light on the Recent BOTOX® Deaths

Chicago based plastic surgeon speaks out on BOTOX® safety

Recently, we have learned that the FDA approved wrinkle eraser could be the cause for some fifteen reported deaths across the world. Renowned plastic surgeon Dr. Gregory Wiener wants to shed some light and calm some fears on this subject.

Dr. Wiener states, “Botox has been approved for use as a wrinkle eraser for several years now; it is the off-label use that is causing these unfortunate deaths.” Dr. Wiener goes on to explain that the typical dosage for wrinkle erasing is between 25-50 units of Botox, whereas when using Botox to ease muscle spasms or spasticity, doctors are finding they need to use 500 or 600 units, over ten times the customary amount. “The off-label use of Botox to treat muscle spasm diseases such as cerebral palsy is the reason for these fatalities.”

ABOUT DR. WIENER

Dr. Greg Wiener M.D. FACS is a board certified cosmetic and reconstructive surgeon who has been practicing at Resurrection Hospital for the past 9 years. He was named a Consumer Reports “Top Surgeon” and completed his residency at the University of Illinois at Chicago. Dr. Wiener has been featured in several media outlets such as E! News Live, WFLD-TV, WMAQ-TV, Univision Online, Oxygen Magazine, Healthy and Fit Magazine, Forbes, US Weekly, Life & Style Weekly, Globe, Daily Herald, Chicago Sun Times and the Today Show Website.

Gregory A. Wiener, M.D.
www.TheArtofPlasticSurgery.com

Thursday ~ February 7, 2008

FDA Clears NuFace® Device - The World’s First & Only At Home Handheld Facial Toning Device

THE BEAUTY INDUSTRY GETS A FACELIFT

FDA Clears NuFace® Device - The World’s First & Only At Home Handheld Facial Toning Device

New York, New York (February 7, 2008) – Beauty icon Audrey Hepburn once said, “The beauty of a woman changes with the passing years, it is up to her to manage the change she desires.” Now, more than 55 years after Hepburn’s emergence as a beauty icon, her philosophy has enlightened millions of women to the benefits of taking advantage of all science has to offer when it comes to their appearance. While science has not yet discovered the fountain of youth, Carol Cole Company’s NuFace® device is today’s most effective way to erase the signs of aging from the face.

What is the NuFace® device?
The NuFace® device was cleared by the FDA as an at-home cosmetic device that safely and effectively improves the appearance of the face through the use of microcurrent technology. The muscles and skin tissues are lifted and toned utilizing the NuFace’s non-invasive and gentle electrical stimulation. “The NuFace® device is bringing anti-aging to the next level,” says Dr. Peter Pugliese, a renowned physician and lead medical consultant of clinical studies for the Carol Cole Company. “Where Botox has made the anti-aging market turn on its heels, the NuFace® device is a new and innovative skin health product.”

What is Microcurrent Technology?
Currently, microcurrent technology is used in luxurious spas to lift and tone the face, reduce and eliminate fine lines and wrinkles, improve facial circulation, skin exfoliation, lymphatic drainage, treat sun damage and skin pigment as well as improve product penetration. Emil Y. Chi, PhD, director of the University of Washington’s department of pathology, performed clinical studies using microcurrent technology. He notes, “The fact that this technology works in harmony with the body is evident. Examination of skin tissue treated with microcurrents showed a 45% increase in the number of elastin fibers in the dermis, collagen thickness in connective tissue increased 10%, and the number of blood vessels increased by 35%. The application of microcurrents to the skin and tissue produced a firmer and tighter feeling on the skin’s surface.”

How Does the NuFace® device Work?
The NuFace® device can be used daily as an addition to a healthy skin regimen. A non-invasive approach to facial rejuvenation, the NuFace® device is used to improve muscle tone in the face. The user glides the NuFace® device along the contour of the face while a gentle alternating current is emitted through dual spherical probes. In addition, the NuFace® device compliments many professional treatments including LED, laser, invasive procedures and injectables such as Botox.

100% Safe and Effective
In a third party NuFace® efficacy study, five test subjects used NuFace® for 5 minutes a day for 30 consecutive days. Within only a four week evaluation there was a positive indication of the efficacy of the NuFace® Microcurrent System. The study revealed a 67% reduction in fine facial lines and wrinkles, 13% reduction in sagging skin, 31% reduction in skin roughness and surface irregularities. “NuFace® made the skin appear tighter and well toned”, said Dr. Pugliese.

Who Should Use the NuFace® Device?

The best candidate is anyone who wishes to maintain or gain a youthful appearance. Younger consumers can use the NuFace® device to prevent some of the aesthetic effects of aging while older consumers can rejuvenate their faces and reduce the appearance of fine lines and wrinkles.

“More than ever, Baby Boomers are becoming savvy about their looks and the anti-aging options they want to undergo. It is a group of patients that has been steadily increasing and has become more educated about their health than ever before,” said Dr. Pugliese. With 30% of the U.S. population made up of Baby Boomers, the demand for anti-aging products is at its highest rate.
According to the Rehabilitation Institute of Chicago (RIC), among Baby Boomers who were surveyed, 79% felt they would have no serious physical limitations until they reached the age of 80 or older. The Baby Boomer generation has seen the most dramatic leaps in medical science and life expectancy of any other generation. They are no strangers to seeking a little assistance to looking and feeling great as they grow old.

How Much Does it Cost?
The NuFace® device is currently retailed at spas, medispas, and select online retailers including www.myNuFace.com. The NuFace® device retails for $379.00. The NuFace Kit includes: the NuFace® device, Derma-Gel, Optimizing Mist, Instructional DVD, One year warranty and 30-day money back guarantee. For complete information on the NuFace® device, please visit www.myNuFace.com.

“Skin care has truly evolved over the years and has become a necessity in American culture,” says Carol Cole, founder and creator of Carol Cole Company and the revolutionary NuFace® device. “The changing face of skin care is driven by factors such as lifestyle trends, technological advancements and cultural truisms. The beauty industry is perpetually challenged with flash-in-the-pan products that lack the research and professional expertise demanded by consumers. At The Carol Cole Company, we are devoted to research, product quality, and the understanding of a customer’s well-being. We create a beauty experience that exceeds our customers’ expectations and continues to raise the bar for excellence.”

About The Carol Cole Company
The Carol Cole Company is a cosmetic and esthetic technology company focused on the development of contemporary devices and beauty treatments that aid in facial rejuvenation. Comprised of experts from esthetic and consumer product industries, the company is dedicated to providing innovative and effective esthetic products that are designed for professional and home use.

About The Carol Cole Skincare Collection
The Carol Cole Skincare Collection is a high-quality cosmeceutical skincare collection that has been formulated by a team of physicians combining a unique blend of ingredients which have been ionized or “electrically” charged to allow for increased product absorption. The Carol Cole Skincare Collection offers a unique blend of ingredients including Peptides (Arigeline and Matrixyl), Copper, DMAE, Vitamin C, Alpha Hydroxy Acid (AHA), Co-enzyme Q10, Hyaluronic Acid and Alpha Lipoic Acid. Utilize the Carol Cole Collection on its own or to enhance NuFace results!

The Carol Cole Company
www.myNuFace.com
www.carolcolecompany.com

Wednesday ~ February 6, 2008

Renowned NJ Plastic Surgeon at Forefront of New Minimal Incision/Minimal Scar Breast Lift

Renowned NJ Plastic Surgeon at Forefront of New Minimal Incision/Minimal Scar Breast Lift

(Montclair, NJ) It is part of human nature and a fact that as women age breasts can lose their shape and firmness and begin to sag. Loss of skin elasticity, gravity and other factors such as weight loss, pregnancy and breast-feeding ultimately affect the shape and firmness of the breasts. Patients who are generally satisfied with the size of their breasts can have a breast lift to raise and firm them, resulting in a more youthful breast contour.

Medically known as mastopexy, or breast lift, surgeons have been using the common method of lifting the breasts making several incisions. One incision is made around the areola. Another runs vertically from the bottom edge of the areola to the crease underneath the breast and a third incision is horizontal beneath the breast following the natural curve of the breast crease. Unfortunately, most patients fear undergoing the procedure since they are reluctant to accept the associated scars.

Until now the traditional breast lift has been the gold standard with plastic surgeons. Yet, with the introduction of the new Quill “barbed” suture, Dr. Allen Rosen, board certified plastic surgeon and a spokesperson for the American Society of Plastic Surgery, is perfecting a new breast lift technique with minimal incisions just around the areola.

The Quill suture is a barbed absorbable suture that anchors to the tissues in the body and allows surgeons to lift areas with small incisions. Dr. Rosen is using the Quill suture in the classic breast lift by inserting the suture through a small incision tunneling beneath the skin upwards to lift the breasts back to a higher position. Fine collagen microfilaments then grows around the sutures, which eventually dissolve to help the breasts remain in an upright position. Dr. Rosen states, “This new suture technology will revolutionize the way breast, body contouring and facial rejuvenation will be performed in the future. The material eliminates the need to tie knots and thus allows surgeons to operate faster, through smaller incisions and provides greater strength in repairing and lifting tissues.”

“In working closely with the Quill manufacturers, it is suggested that that only properly trained surgeons use this product. The suture should be used in open procedures within the tissues allowing for a lasting effect. The suture dissolves within several months so there is no lingering long-term foreign body in the soft tissues,” says Rosen.

Allen D. Rosen, M.D.
The Plastic Surgery Group
www.LoveYourLook.com

Monday ~ February 4, 2008

Thermage Introduces Cellulite Product

Thermage Introduces Cellulite Product

ThermaTip(tm) CL Designed to Improve the Appearance of Cellulite on the Thigh and Buttocks Area in a Single Treatment

HAYWARD, Calif., - Thermage, Inc. (NASDAQ:THRM) announced the introduction of the ThermaTip CL treatment tip and the Cellulite procedure by Thermage at the American Academy of Dermatology’s (AAD) annual meeting in San Antonio, Texas. The Cellulite procedure by Thermage uses the FDA cleared ThermaCool system for the temporary improvement in the appearance of cellulite.

According to a study published in 2007 by the Millennium Research Group, nearly 90 percent of women experience some degree of cellulite, and demand for non-invasive cellulite treatments in the U.S. is expected to nearly double to over 750,000 procedures per year by 2011.

The Cellulite procedure by Thermage and the ThermaTip CL treatment tip are the result of 21 months of clinical and technology development. The advanced deep heating ThermaTip CL rebuilds collagen connective tissues and improves blood flow to the tissue helping to improve the smooth appearance of the skin’s surface.

“Clinical evaluations have demonstrated that Thermage technology noticeably reduces the appearance of cellulite after just a single treatment,” said Stephen J. Fanning, Chairman of the Board, President and Chief Executive Officer at Thermage. “We have conducted vigorous research since the spring of 2006 to develop a treatment tip that offers optimal results for our customers and their patients. The ThermaTip CL provides a unique option to physicians for the many patients who want to treat cellulite, but have yet to find something that produces significant results in a single treatment.”

“Many of my patients have cellulite, and despite rigorous exercise and diet efforts, there is not much that they can do to minimize the appearance of cellulite,” said Dr. Karyn Grossman, a cosmetic dermatologist with offices in Manhattan, NY and Santa Monica, CA. “I am thrilled to be able to offer patients an option for this condition that produces results in one treatment session without surgery, injections or downtime.”

All Thermage procedures use a unique, patented monopolar capacitive radiofrequency technology for controlled heating of tissue that is backed by years of clinical research. The technology has been written about in over 45 peer-reviewed articles and safely used on over 450,000 patients worldwide to stimulate existing collagen and promote new collagen growth. Patients benefit from a single treatment and results can be subtle to dramatic depending on the individual patient.

In 2007 Thermage introduced the new ThermaCool® NXT™ system, which shortens procedure times and is more comfortable and flexible for practitioners to use than its predecessor system. The ThermaTip CL treatment tip is compatible with all existing ThermaCool systems.

About Thermage, Inc.
Thermage’s innovative technologies provide unique non-invasive procedures designed to smooth, tighten and contour skin, significantly expanding the non-invasive aesthetic applications physicians can offer to the rapidly growing “anti-aging” market.

Claims are based upon FDA clearance for the non-invasive treatment of wrinkles and rhytids, including the upper and lower eyelids, and our FDA clearance for the temporary improvement in the appearance of cellulite.

Side effects are generally mild and may include redness, swelling, blisters, bumps and rare instances of surface irregularities.

Thermage, ThermaCool, NXT, ThermaTip and Body by Thermage are trademarks of Thermage, Inc.

Thermage, Inc.
510.259.7117
www.thermage.com

Wednesday
September 8, 2010

Press Releases:

Syndication:

Admin:

the leading physician journal for aesthetics and wellness